Table 2.

Serum levels of glycoproteins and their fucosylated glycoforms in prostate cancer patients detected by multiplex immunoassay.

	Glycoproteins X±SD (range) ng/mL	Fucosylated form X±SD (range) ng/mL	% Fucosylated X±SD (range)
PSA	15.13±2.14 (1.93-54.47)	6.27±1.99 (0.24-8.76)	27.01%±3.62% (8.31%-170.06%)
TIMP1	80.80±4.44 (40.75-173.41)	25.34±1.84 (8.28-58.36)	34.42%± 2.83% (8.66%-92.87%)
tPA	4.89±0.32 (1.12-10.39)	1.59±0.13 (0.47-5.82)	33.95%± 1.94% (18.31%- 80.06%)

PSA: prostatic-specific antigen; TIMP1: tissue inhibitor of metallopeptidase 1; tPA: tissue plasminogen activator; Pca: prostate carcinoma.